• Create admissions profile
  • Check on application status

Apply Now
Connect with us

Robert J. Snyder, D.P.M. MSc, C.W.S.


Wound Care

Board Certifications:

  • Diplomat, American Board of Podiatric Surgery, Board Certified in Foot and Ankle Surgery
  • Diplomat, American Board of Wound Management, Certified Wound Specialist (C.W.S.)
  • Fellow, American College of Foot and Ankle Surgeons

Professional Memberships:

  • Immediate- Past President and Board Member of Association for the Advancement of Wound Care (AAWC)
  • Past President and Board Member of American Board of Wound Management (ABWM)

Hospital Affiliations:

  • Jackson North
  • Hialeah Hospital
  • Mt Sinai
  • University Of Miami
  • Coral Springs/Broward Health
  • University Hospital & Medical Center
  • Northwest Medical Center

Medical School:

  • New York College of Podiatric Medicine, New York, NY
  • Cardiff University, University of Wales School of Medicine, UK


  • Jewish Memorial Hospital, New York, NY

Academic Appointments:

  • Professor & Director of Clinical Research Barry University SPM, Brand Research Center
  • Adjunct Professor, Temple University School of Podiatric Medicine
  • Medical Advisory Board & Wound Care Course Lecturer Healogics

Committee Memberships:

  • Editorial Board: Ostomy Wound Management, Wounds, Podiatry, Management
  • Periodic Review: NEJM, Lancet


  • Snyder, RJ, Vazales, R. Acroangiodermatitis (Pseudo-Kaposi’s Sarcoma) Seen in Conjunction with Marfan Syndrome and a Hypercoaguable State: Is There a Link? Wounds. 2014; 26(3):72-76.
  • Snyder, RJ, Serena, TE, Zelen, CM. A prospective, randomised comparative study of weekly versus biweekly application of dehydrated human anion/chorion membrane allograft in the management of diabetic foot ulcers. International Wound Journal. 2014; 10.1111/ 12242
  • Snyder, RJ, Cullen, B, Nisbet, LT. An audit to assess the perspectives of US wound care specialists regarding the importance of proteases in wound healing and wound assessment. International Wound Journal. 2013; 10:653-660
  • Snyder, RJ, Kirsner, RS, Marston, WA et al. Durability of healing from spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: A 6-month follow-up. Wound Repair and Regeneration. 2013;21:682-687
  • Snyder RJ, Cook RG. Particularities in wound healing in diabetic neuro-ischemic foot wounds: why the angiosome model may be useful. In: Angiosomes Applications in Critical Limb Ischemia: In search of relevance. (V. Alexandrescu, (Ed)). 2013. Edizioni Minerva Medica: Turin, Italy.
  • Wilson TC, Snyder RJ, Southerland C. Bullosis Diabeticum: Is there a correlation between hyperglycemia and this symptomalogy? Wounds. 2012;24(12):350-355
  • Snyder RJ, Fetterolf DE. Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. Wounds. October 2012;24(10): 299-307
  • Snyder RJ, Cullen B, Nisbet LT. An audit to assess the perspectives of US sound Care specialists regarding the importance of proteases in wound healing and wound assessment. International Wound Journal. 2012; doi: 10.1111/j.1742-481X.2012.01040.x
  • Badahdah H, Snyder RJ, O’Connor C. et al. Mixed Etiology Hydroxyurea- Related lower leg ulcer that masqueraded as sequelae from sickle cell disease and venous insufficiency. Wounds. 2012;24(9): 254-257
  • Kirsner, RS, Marston WA, Snyder RJ et al. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial. The Lancet. 15, 2012; 380 (9846): 977-985
  • Sibald R, Snyder RJ, Botros M, et al. Role of a point –of-care protease activity diagnostic test in Canadian clinical practice: A Canadian Expert Consensus. Advances in Skin & Wound Care. 2012;25(6): 267-275
  • Serena T, Bates-Jensen B, Carter MJ, Cordrey R, Snyder RJ, et al. Consensus principles for wound care research obtained using a Delphi process. Wound Repair and Regeneration. 2012 ;20(3) : 284-293
  • Warriner RA, Snyder RJ, Cardinal MH. Differentiating diabetic foot ulcers that are unlikely to heal by 12 weeks following achieving 50% percent area reduction at 4 weeks. International Wound Journal 2011;8:632-637
  • Snyder R et al. International Consensus. The role of proteases in wound diagnostics. An expert working group review. London: Wounds International, 2011; Supplement: 1-13
  • Snyder RJ, Kirsner RS, Warriner RA, Lavery LA, Hanft JR, Sheehan, P. Consensus Recommendations on Advancing the Standard of Care for Treating Neuropathic Foot Ulcers in Patients with Diabetes. Ostomy Wound Management, HMP Communications. 2010; Supplement : 1-23
  • Snyder RJ, Cardinal M, Dauphinee DM, Stavosky J. A Post-hoc Analysis of Reduction in Diabetic Foot Ulcer Size at 4 Weeks as a Predictor of Healing by 12 Weeks. Ostomy Wound Management, HMP Communications. March 2010; 56(3): 44-50
  • Snyder RJ, Hanft J. Diabetic Foot Ulcers- Effects on Quality of Life, Costs, and Mortality and the Role of Standard Wound Care and Advanced-Care Therapies in Healing: A Review. Ostomy Wound Management, HMP Communications. November 2009; 55(11): 30-36
  • Snyder RJ. Skin Cancer and Wounds in the Geriatric Population: A Review. Ostomy Wound Management, HMP Communications. April 2009;55(4):64-76
  • Snyder R. Skin cancers and wounds in the geriatric population. In: Geriatric Dermatology (R. Norman, ed). 2006
  • Snyder RJ. Physiology of Wound Healing. Chapter in Wound Healing and Suction Wound Therapy, Published in China and translated into mandarin, 2005
  • Snyder RJ, Hanft J, Serena T. The changing microenvironment of chronic wounds. June 2005 as a supplement to Wounds and Ostomy Wound Management
  • Snyder RJ. Treatment of nonhealing ulcers with allograft. Chapter in Clinics in Dermatology, Elsevier, Inc. (2005) 23, 388-395

Scientific and Research Presentations:

Dr Snyder is a world renown expert on would healing and is in high demand as an expert speaker. Over the past decade he has been a regular presenter for the European Wound Management Association and at the Symposium on Advanced Wound Care

Research Projects Serving as Principal Investigator:

Dr Snyder is a skilled clinical researcher serving as the Principal Investigator on many clinical trials. He is currently involved as the Principal Investigator on the following clinical trials:

  • DermaSciences, Protocol Number DSC 127-2012-01 “A Randomized, Double-Blind, Parallel-group, Vehicle-controlled Phase 3 Clinical Trial to Evaluate the efficacy and Safety of DSC127 in Treating Non-healing Foot Ulcers in Subjects with Diabetes Mellitus” Present
  • Xoma, LLC, Protocol X052170 “An Open-Label, Proof of Concept Study of Gevokizumab in the Treatment of the Acute, Inflammatory Phase of Pyoderma Gangrenosum” Present
  • SanuWave, Protocol SAN12-DERM02 “A Double-Blind, Multi-center, Randomized, Sham-Controlled, Parallel Group Comparison of the dermaPACE® (pulse Acoustic Cellular Expression) Device in Conjunction with Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers” October 2013 - Present
  • CoDa Therapeutic, Protocol Number NEX-ULC-011 “A Randomized, Prospective, Double-blind, Vehicle-controlled, Dose-ranging, Multi-center Study to Assess the Safety and Clinical Effect of Nexagon® (NEXAGON) in the Treatment of Subjects with a Diabetic Foot Ulcer” - Present
  • Macrocure , Protocol Number MC-102 CureXcell™ “A Phase III, Multinational, Multicenter, Randomized, Double-Blind, Parallel-Group, Sham-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of CureXcell™ as an adjunct to Good Wound Care Measures in Treating Lower Extremity Chronic Ulcers in Adults with Diabetes Mellitus” October 2013 - Present

Oh oh ....

We are sorry but it appears that JavaScript is disabled on your browser.
Our site is very interactive and it requires JavaScript to be enabled.
Click on the link below for instructions on how to enable JavaScript on your browser.

Enable JavaScript on your browser